NEUVIPDA Trademark

Trademark Overview


On Tuesday, November 14, 2023, a trademark application was filed for NEUVIPDA with the United States Patent and Trademark Office. The USPTO has given the NEUVIPDA trademark a serial number of 98268772. The federal status of this trademark filing is REGISTERED as of Tuesday, October 15, 2024. This trademark is owned by GlaxoSmithKline Biologicals SA. The NEUVIPDA trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines
neuvipda

General Information


Serial Number98268772
Word MarkNEUVIPDA
Filing DateTuesday, November 14, 2023
Status700 - REGISTERED
Status DateTuesday, October 15, 2024
Registration Number7534907
Registration DateTuesday, October 15, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 30, 2024

Trademark Statements


Goods and ServicesVaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 14, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxoSmithKline Biologicals SA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Tuesday, November 14, 2023NEW APPLICATION ENTERED
Thursday, February 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 20, 2024ASSIGNED TO EXAMINER
Friday, June 21, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 10, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 30, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 30, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 15, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 15, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords


neuvipda vaccines